A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 45
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : DF
Long Form : distant failure
No. Year Title Co-occurring Abbreviation
2021 Impact of neutrophil-to-lymphocyte ratio throughout the course of chemoradiotherapy on overall survival and distant failure in unresectable stage III non-small cell lung cancer. NLR, NSCLC, OS
2021 To biopsy or not to biopsy? Outcomes following stereotactic body radiotherapy (SBRT) for biopsy-confirmed versus radiologically-diagnosed primary lung cancer in a single Australian institution. LF, OS, SBRT
2020 Comparative Analysis of 5-Year Clinical Outcomes and Patterns of Failure of Proton Beam Therapy Versus Intensity Modulated Radiation therapy for Prostate Cancer in the Postoperative Setting. BF, IMRT, LF, MVA, PBT, RF
2020 Impact of routine surveillance imaging on detecting recurrence in human papillomavirus associated oropharyngeal cancer. CRT, DR, HPV, LRF, OPC, SPT
2020 Predictive value of interim 18F-FDG-PET in patients with non-small cell lung cancer treated with definitive radiation therapy. LRC, OS, RT
2020 Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure. CI, HR, LF, OS, SABR
2019 Local and regional treatment response by 18FDG-PET-CT-scans 4 weeks after concurrent hypofractionated chemoradiotherapy in locally advanced NSCLC. MTV, OS, TLG
2019 Moderately Hypofractionated Radiotherapy Alone for Stage I-IIB Non-small Cell Lung Cancer. CTCAE, ECOG, HRT, LRF, NSCLC, OS, SBRT
2019 Optimal timing and clinical value of radiotherapy in advanced ALK-rearranged non-small cell lung cancer with or without baseline brain metastases: implications from pattern of failure analyses. BBM, OF, TKIs
10  2019 Predictive Values of MRI and PET Derived Quantitative Parameters for Patterns of Failure in Both p16+ and p16- High Risk Head and Neck Cancer. ADC, BV, GTV, HNC, QI
11  2019 Single-fraction Stereotactic Body Radiation Therapy versus Conventionally Fractionated Radiation Therapy for the Treatment of Prostate Cancer Bone Metastases. BF, CFRT, CI, HR, IFF, SBRT
12  2019 Stereotactic Radiosurgery for Pediatric and Adult Intracranial and Spinal Ependymomas. LF, SRS
13  2018 Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas. CCA, GBC, LRF, OS
14  2018 Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis. EBRT, IORT, LC, OS
15  2018 Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas. CI, HR, IRB, LR, OS
16  2018 Metabolic positron emission tomography parameters predict failure patterns in early non-small-cell lung cancer treated with stereotactic body radiation therapy: a single institution experience. NSCLC, RF, SBRT
17  2018 Patterns of Distant Failure by Intrinsic Breast Cancer Subtype in Premenopausal Women Treated With Neoadjuvant Chemotherapy. HER2, NAC, OS
18  2018 Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704. LRR, SMS
19  2018 Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation. CRT, LR, PDAs
20  2018 Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC). BED, CONV, KPS, LF, NF, NSCLC, OS, PS, SBRT
21  2017 Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer. CI, CRT, DFS, LARC, LF, OR, OS, OXP
22  2017 Differences in the outcomes and complications between elderly and younger uterine cervical cancer patients treated by definitive radiotherapy - A propensity score-matched study. CSS, LF, OS
23  2017 Identifying the Optimal Radiation Dose in Locally Advanced Non-Small-cell Lung Cancer Treated With Definitive Radiotherapy Without Concurrent Chemotherapy. CI, CRT, HR, LF, NSCLC, OS, RT
24  2017 Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancer. ALN, CT, GC, LP, PFS, POF, RCT, RT
25  2015 Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase II trial. IMRT, LC, OS, RFS
26  2015 Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience. nCRT, OS
27  2015 Prognostic Value of Log Odds of Positive Lymph Nodes after Radical Surgery Followed by Adjuvant Treatment in High-Risk Cervical Cancer. DFS, FIGO, LN, LNR, LODDS, OS
28  2015 Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer. CRT, CT, DFS, LRF, LS, MTV, OS, PET, SCLC, SUV
29  2015 Resection Followed by Involved-Field Fractionated Radiotherapy in the Management of Single Brain Metastasis. BM, IFRT, LR, OS
30  2014 Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial. GTV, KPS, LR, MRI, OS, PTV, RN, SRS
31  2014 Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer. DFS, LRF, OS, RT, SP
32  2014 Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. CRT, IC, OS, RFS, SCCHN
33  2013 Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. BCT, LNs, LR
34  2013 RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma. CI, DFS, LRF, OS, PAF
35  2013 Stereotactic body radiation therapy in octogenarians with stage I lung cancer. CI, CT, LF, NF, NSCLC, OS, SBRT
36  2012 The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy. BT, CCRT, DSM, PF
37  2012 Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer. BF, FFBF, FFDF, FFLF, LF
38  2007 Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy. EPP, LF, MDRT
39  2006 Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis. bNED, CSF, NB, OS, PSA, RT
40  2006 Extracranial chordoma: Outcome in patients treated with function-preserving surgery followed by spot-scanning proton beam irradiation. CGE, LF, OS, PFS, PT
41  2006 Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials. LN, LRF, PMRT
42  2005 Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis. ASTRO, BF, CF, LF, PSA, RT
43  2004 Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. LRF, PMRT
44  1999 Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. LRF
45  1998 Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure. LF, PCa, PSA, RT, TRUS